Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Shandong Pharmaceutical Glass Co's Revenue for the
three
months ended in Mar. 2026 was ¥1,219 Mil. Shandong Pharmaceutical Glass Co's average Accounts Receivable for the
three
months ended in Mar. 2026 was ¥953 Mil.
Hence, Shandong Pharmaceutical Glass Co's Receivables Turnover for the
three
months ended in Mar. 2026 was 1.28.
Shandong Pharmaceutical Glass Co (SHSE:600529) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Shandong Pharmaceutical Glass Co Receivables Turnover Related Terms
Shandong Pharmaceutical Glass Co Receivables Turnover Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Pharmaceutical Glass Co Receivables Turnover Chart
SHSE:600529 vs SW, PKG, IP: Receivables Turnover Comparison
For the Packaging & Containers subindustry, Shandong Pharmaceutical Glass Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Pharmaceutical Glass Co Receivables Turnover vs Packaging & Containers Industry
For the Packaging & Containers industry and Consumer Cyclical sector, Shandong Pharmaceutical Glass Co's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Shandong Pharmaceutical Glass Co's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Pharmaceutical Glass Co (SHSE:600529) has a Receivables Turnover of 1.28 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Shandong Pharmaceutical Glass Co and its competitors. According to the industry distribution chart, Shandong Pharmaceutical Glass Co ranks #249 out of 399 companies in the Packaging & Containers industry, placing it in the top 62.4%.
Is Shandong Pharmaceutical Glass Co's Receivables Turnover too high?
Shandong Pharmaceutical Glass Co's current Receivables Turnover is 1.28. The Packaging & Containers industry median Receivables Turnover is 5.41. Shandong Pharmaceutical Glass Co's value of 1.28 is 76.3% below this industry median. Based on the distribution chart, Shandong Pharmaceutical Glass Co ranks #249 out of 399 companies in the Packaging & Containers industry, which is below the industry midpoint. Overall, Shandong Pharmaceutical Glass Co has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Pharmaceutical Glass Co's Receivables Turnover compare to SW and PKG?
According to the Packaging & Containers industry distribution chart, Shandong Pharmaceutical Glass Co ranks #249 out of 399 companies for Receivables Turnover. This places Shandong Pharmaceutical Glass Co in the lower half of its industry. The industry median Receivables Turnover is 5.41. Shandong Pharmaceutical Glass Co's value of 1.28 is 76.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Packaging & Containers company?
The median Receivables Turnover among Packaging & Containers companies is 5.41, based on 399 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Pharmaceutical Glass Co's current Receivables Turnover of 1.28 is 76.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Shandong Pharmaceutical Glass Co and its competitors. For the Packaging & Containers industry, the median Receivables Turnover is 5.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Pharmaceutical Glass Co's current Receivables Turnover is 1.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Pharmaceutical Glass Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Pharmaceutical Glass Co (SHSE:600529) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥24.69, compared to a current price of ¥19.01 — trading 23% below its estimated fair value. The current Receivables Turnover is 1.28 and 76.3% below the Packaging & Containers industry median of 5.41. Shandong Pharmaceutical Glass Co's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Shandong Pharmaceutical Glass Co (SHSE:600529), the current Receivables Turnover is 1.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Pharmaceutical Glass Co (SHSE:600529) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Pharmaceutical Glass Co stock appears to be undervalued.
The current stock price of ¥19.01 is trading 23% below its estimated GF Value™ of ¥24.69.
GuruFocus considers Shandong Pharmaceutical Glass Co to be Modestly Undervalued.
Key valuation signals for SHSE:600529:
Receivables Turnover: 1.28
GF Value™: ¥24.69 vs. price of ¥19.01 (23% below fair value)
Industry Position: 76.3% below the Packaging & Containers median (#249 of 399)
No single metric tells the full story. See the SHSE:600529 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Pharmaceutical Glass Co Ltd is a pharmaceutical glass packaging product company. Its pharmaceutical glass packaging products and butyl rubber series products which service object of pharmaceutical, food, daily necessities industries. The products include for moulded injection vial for antibiotics series, tubular glass vial series, amber glass bottle series, neutral borosilicate glass bottle series, infusion bottle series, cosmetic bottles series, food bottles series, butyl rubber stopper series, prefillable syringes series, and aluminum-plastic cap series.
92GF Score
Get the complete analysis for SHSE:600529
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600529 has been successfully added to your 
